Physician
Genesis Medical Group LLC
Genesis Medical Group LLC was paid $15.15M by Medicaid between Jan 2018 and Dec 2024, across 207 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoGENESIS MEDICAL GROUP LLC
ZANESVILLE, OH 43701
ZANESVILLE, OH 43701
33aNPI1063663433assigned 10/03/2008
33bProvider typeAllergy Physician
28Total paid$15.15M
24GClaims1,617,342
24DCodes billed207
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy Physician providers in Ohio
Rank by total paid#2 of 13
Median peer was paid$159K
This provider vs. median95×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 92,084 | $2.13M | |
| 2019 | 223,037 | $2.51M | |
| 2020 | 300,672 | $1.92M | |
| 2021 | 248,776 | $1.97M | |
| 2022 | 265,343 | $1.92M | |
| 2023 | 288,403 | $2.45M | |
| 2024incomplete | 199,027 | $2.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 138,342 | 126,895 | $4.65M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 117,294 | 110,678 | $4.28M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.5% | 20,155 | 19,377 | $981K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.0% | 10,680 | 10,142 | $600K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.7% | 5,671 | 5,565 | $401K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.6% | 12,735 | 12,361 | $398K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.3% | 4,922 | 4,636 | $345K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.7% | 1,958 | 1,835 | $258K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,077 | 4,947 | $132K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,542 | 10,851 | $132K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,867 | 5,604 | $129K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 3,420 | 2,821 | $116K |
195 more codes
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 20,845 | $114K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 2,056 | $112K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 6,075 | $103K |
| 51701 | <1% | 3,914 | $101K | |
| 92557 | <1% | 3,536 | $94K | |
| 20610 | <1% | 2,456 | $91K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 2,247 | $81K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,026 | $80K |
| 52000 | <1% | 1,414 | $78K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 354 | $74K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 166 | $72K |
| 99243 | <1% | 1,392 | $72K | |
| 95811 | <1% | 1,215 | $65K | |
| 51729 | <1% | 556 | $64K | |
| 20611 | <1% | 1,289 | $60K | |
| 95886 | <1% | 2,569 | $59K | |
| 93000 | <1% | 6,340 | $58K | |
| 93458 | <1% | 686 | $57K | |
| 93971 | <1% | 3,660 | $52K | |
| 93970 | <1% | 2,552 | $52K | |
| 51784 | <1% | 933 | $48K | |
| 92567 | <1% | 4,307 | $44K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,552 | $41K |
| 52281 | <1% | 439 | $40K | |
| 51797 | <1% | 556 | $37K | |
| 94060 | <1% | 3,888 | $35K | |
| 93296 | <1% | 3,352 | $34K | |
| 99406 | <1% | 5,389 | $33K | |
| 36475 | <1% | 103 | $31K | |
| 99152 | <1% | 3,689 | $30K | |
| 31575 | <1% | 583 | $30K | |
| 43248 | <1% | 308 | $29K | |
| 73110 | <1% | 1,779 | $29K | |
| 93018 | <1% | 3,072 | $26K | |
| 95913 | <1% | 199 | $24K | |
| 93294 | <1% | 1,405 | $24K | |
| 62323 | <1% | 371 | $23K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 383 | $23K |
| 99442 | <1% | 1,421 | $22K | |
| 93295 | <1% | 691 | $21K | |
| 73030 | <1% | 1,436 | $21K | |
| 93298 | <1% | 1,217 | $19K | |
| 99443 | <1% | 845 | $19K | |
| 95816 | <1% | 966 | $18K | |
| 51700 | <1% | 515 | $18K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,801 | $16K |
| 99350 | Prolong home eval add 15m | <1% | 440 | $15K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 450 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,023 | $13K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 924 | $13K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 200 | $13K |
| 31231 | <1% | 162 | $12K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 384 | $12K |
| 95911 | <1% | 209 | $12K | |
| 94729 | <1% | 4,086 | $12K | |
| 73130 | <1% | 715 | $12K | |
| 51798 | <1% | 1,584 | $12K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 447 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,797 | $11K |
| 94726 | <1% | 3,267 | $11K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 520 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,225 | $10K |
| 99441 | <1% | 976 | $10K | |
| 95251 | <1% | 1,496 | $9K | |
| 27096 | <1% | 159 | $9K | |
| 93350 | <1% | 219 | $9K | |
| 97597 | <1% | 1,475 | $8K | |
| 81003 | <1% | 6,453 | $8K | |
| 95909 | <1% | 223 | $8K | |
| 73564 | <1% | 454 | $8K | |
| 99245 | <1% | 82 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 396 | $8K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 721 | $8K |
| 11721 | <1% | 762 | $8K | |
| 73620 | <1% | 497 | $7K | |
| 90686 | <1% | 654 | $7K | |
| 93880 | <1% | 495 | $6K | |
| 29848 | <1% | 25 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 360 | $6K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 42 | $6K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 91 | $6K |
| 93272 | <1% | 285 | $5K | |
| 93280 | <1% | 249 | $5K | |
| 43249 | <1% | 105 | $5K | |
| 93016 | <1% | 337 | $5K | |
| 99254 | <1% | 55 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 65 | $4K |
| 95908 | <1% | 129 | $4K | |
| 52260 | <1% | 47 | $4K | |
| 77014 | <1% | 152 | $4K | |
| 73630 | <1% | 214 | $3K | |
| 22853 | <1% | 15 | $3K | |
| 20553 | <1% | 134 | $3K | |
| 64493 | <1% | 67 | $3K | |
| 81002 | <1% | 1,376 | $3K | |
| 95910 | <1% | 66 | $3K | |
| 76801 | <1% | 42 | $3K | |
| 69210 | <1% | 177 | $3K | |
| 59025 | Fetal non-stress test | <1% | 97 | $3K |
| 77427 | <1% | 28 | $3K | |
| 52356 | <1% | 14 | $3K | |
| 51741 | <1% | 612 | $3K | |
| 99255 | <1% | 26 | $2K | |
| 93922 | <1% | 278 | $2K | |
| 99223 | Prolong inpt eval add15 m | <1% | 45 | $2K |
| 95885 | <1% | 222 | $2K | |
| 99349 | <1% | 98 | $2K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 49 | $2K |
| 93925 | <1% | 127 | $2K | |
| 99459 | <1% | 169 | $2K | |
| 52310 | <1% | 13 | $2K | |
| 80305 | <1% | 221 | $2K | |
| 64494 | <1% | 58 | $2K | |
| 73562 | <1% | 98 | $1K | |
| 93299 | <1% | 104 | $1K | |
| 95912 | <1% | 20 | $1K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $1K |
| 73560 | <1% | 65 | $1K | |
| 30802 | <1% | 24 | $1K | |
| 73502 | <1% | 48 | $980.83 | |
| 77334 | <1% | 16 | $979.01 | |
| 76942 | <1% | 26 | $923.39 | |
| 92579 | <1% | 42 | $816.06 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 71 | $804.64 |
| 64615 | <1% | 14 | $744.27 | |
| 81025 | <1% | 115 | $708.37 | |
| 97598 | <1% | 57 | $679.86 | |
| 96127 | <1% | 198 | $668.17 | |
| 77263 | <1% | 14 | $648.33 | |
| 95970 | <1% | 33 | $573.62 | |
| 74420 | <1% | 46 | $472.23 | |
| 11720 | <1% | 93 | $407.54 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 29 | $400.18 |
| 99242 | <1% | 12 | $390.00 | |
| 93308 | <1% | 41 | $341.28 | |
| 93227 | <1% | 12 | $314.76 | |
| 90756 | <1% | 20 | $312.00 | |
| 43450 | <1% | 13 | $303.65 | |
| 73600 | <1% | 25 | $302.03 | |
| 99407 | <1% | 31 | $272.93 | |
| 73610 | <1% | 13 | $269.12 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 54 | $258.58 |
| 94618 | <1% | 13 | $232.42 | |
| 73140 | <1% | 12 | $187.02 | |
| 92504 | <1% | 14 | $138.31 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 120 | $119.10 |
| 94664 | <1% | 13 | $87.81 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 12 | $65.36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 98 | $47.45 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 515 | $22.26 |
| 1036F | 0% | 122,792 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 118,483 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 62,155 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 43,173 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 54,078 | $0.00 |
| 3044F | 0% | 180 | $0.00 | |
| 3017F | 0% | 63,372 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 29,671 | $0.00 |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 10,481 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 10,089 | $0.00 |
| 99024 | 0% | 17,679 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 32,382 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 17,757 | $0.00 |
| 1101F | 0% | 4,877 | $0.00 | |
| G8405 | Lower extremity neurological exam not performed | 0% | 142 | $0.00 |
| 1111F | 0% | 149 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 25 | $0.00 |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 1,636 | $0.00 |
| 3052F | 0% | 13 | $0.00 | |
| 0503F | 0% | 80 | $0.00 | |
| G9908 | Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 114 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 16 | $0.00 |
| 4004F | 0% | 60,060 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 77,434 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 226,008 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 112,341 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 18,397 | $0.00 |
| 3046F | 0% | 3,651 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 9,203 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 9,765 | $0.00 |
| 4040F | 0% | 5,383 | $0.00 | |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | 0% | 2,323 | $0.00 |
| 0502F | 0% | 1,650 | $0.00 | |
| G9709 | Hospice services used by patient any time during the measurement period | 0% | 296 | $0.00 |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 1,126 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,858 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 2,095 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 1,970 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 877 | $0.00 |
| 3045F | 0% | 94 | $0.00 | |
| 2022F | 0% | 421 | $0.00 | |
| 3078F | 0% | 12 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 53 | $0.00 |
| 20930 | 0% | 27 | $0.00 | |
| 3051F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNORMAN, MIKE (CFO)